On Friday, Applied Therapeutics Inc (NASDAQ: APLT) opened lower -10.45% from the last session, before settling in for the closing price of $1.05. Price fluctuations for APLT have ranged from $0.29 to $10.62 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 26.57%. Company’s average yearly earnings per share was noted 24.73% at the time writing. With a float of $125.32 million, this company’s outstanding shares have now reached $141.94 million.
Applied Therapeutics Inc (APLT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Applied Therapeutics Inc is 12.98%, while institutional ownership is 61.16%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.48 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.16) by -0.32. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.73% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.40% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Check out the current performance indicators for Applied Therapeutics Inc (APLT). In the past quarter, the stock posted a quick ratio of 1.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1128.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.44, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.51 in one year’s time.
